...

qSTAR Medical

Visita il sito web

Informazioni sul datore di lavoro

qSTAR Medical aims to improve the lives of patients suffering from End Stage Renal Disease (ESRD) by developing an innovative vascular access device featuring STAR® Biomaterial.

qSTAR Medical SAS was established in late 2011 as a spinout of Healionics USA with the support of OSEO France to develop a needle-free percutaneous port system for improved, pain-free and cost-effective vascular access for hemodialysis (HD) therapy.

There are approximately 20 million patients worldwide who suffer from Chronic Kidney Disease (CKD). An estimated 10% of these patients (2m) have progressed to the severe loss of kidney function defined as End Stage Renal Disease (ESRD) which requires life-sustaining thrice-weekly or daily dialysis therapy. Vascular access is the "Achilles heel" of hemodialysis therapy due to its high complication rates. ESRD patients need and deserve better vascular access options – qSTAR was created to help.

Sede del datore di lavoro

Trova datori di lavoro affini

...
University of Luxembourg Lussemburgo 100 posizioni aperte
...
KU Leuven Lovanio, Belgio 89 posizioni aperte
...
Ghent University Gand, Belgio 69 posizioni aperte
...
ETH Zürich Zurigo, Svizzera 61 posizioni aperte
...
University of Twente Enschede, Paesi Bassi 59 posizioni aperte
Altri datori di lavoro

Questo potrebbe interessarti

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min. di lettura
...
The genetic detectives discovering who we really are University of Turku 5 min. di lettura
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 min. di lettura
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min. di lettura
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min. di lettura
Altre storie